EVE Health Group Ltd (ASX:EVE) ended the 6 October 2026 session at AUD 0.016, rising 14.29% and ranking among the day’s larger percentage movers. The closing performance brings fresh attention to a company whose underlying story is centred on commercial-stage healthcare and pharmaceutical reformulation. …
Argent BioPharma Ltd (ASX:RGT) ended the 6 October 2026 session at AUD 0.034, rising 21.43% and ranking among the day’s larger percentage movers. The closing performance brings fresh attention to a company whose underlying story is centred on clinical-stage biopharmaceutical programs. The market move …
In New York on Monday, the Nasdaq Composite rose 1.05 per cent to 27,477.31, the S&P 500 added 0.66 per cent to 7,773.99 and the Dow Jones Industrial Average gained 0.18 per cent to 51,267.90. The small-cap Russell 2000 climbed 0.72 per cent.
The scale of the problem is stark. In 2019 an estimated 2.6 million deaths in the Asia-Pacific were associated with resistant infections, and more than 680,000 were directly attributable to them. The WHO projects that resistance could cause more than 5 million deaths across …
The prospective study enrolled 143 patients at 10 sites across the United States, all with Wagner grade 1 or 2 diabetic foot ulcers, meaning full-thickness wounds that can extend into deeper tissue. Patients received either weekly applications of Symphony on top of standard care, …
It is the second FDA submission from the company in less than a week. On 1 October, Optiscan filed a separate 510(k) for InForm, a digital pathology platform designed to work alongside InVue. Together the two filings deliver on a target the company had …
The study, led by Dr Harriet Rumgay of the International Agency for Research on Cancer's Cancer Surveillance Branch, estimated that about 2.3 million cancers diagnosed in 2024, or around 12 per cent of the global total, were attributable to infection. Roughly three-quarters of those …
LTR Pharma said ROXUS prescriptions are being received through a men's health telehealth channel, with a licensed US pharmacy handling compounding and distribution. The company did not state how many prescriptions had been fulfilled and did not provide pricing or revenue information for the …
Enlitic Inc. (ASX:ENL) develops artificial intelligence-enabled data management applications for medical imaging, with a focus on standardising, protecting, integrating and analysing healthcare data. On 6 October 2026, the company released Ensight v2.3, extending its platform from eight to 12 commercial applications and adding new …
AFT Pharmaceuticals Limited (ASX:AFP) is a multinational pharmaceutical company that develops, markets and distributes a broad portfolio of proprietary and in-licensed medicines across over-the-counter, prescription and hospital channels. Its 6 October 2026 update outlined regulatory progress for Scomara, continued growth across its operating divisions …